KIT and neoplasm: Additionally, immunohistochemical analysis revealed that FA-mExo-siRNA-c-kit successfully inhibited the expression of c-kit in gefitinib-resistant lung cancer xenografts, and the expression of Ki67 in the tumor tissues of the combined treatment group of mice was significantly reduced (Figure 5E).